Commitments and Contingencies - Additional Information (Details)												12 Months Ended			72 Months Ended	107 Months Ended
	May 17, 2022 USD ($)	Dec. 10, 2021 patent	Jun. 22, 2021 patent	Feb. 26, 2021 patent	Oct. 05, 2020 USD ($) patent	Apr. 30, 2020 patent	Jul. 17, 2019 USD ($)	Jun. 12, 2019 patent	Feb. 13, 2018 patent	Aug. 08, 2016 patent	Sep. 04, 2013 patent	Jul. 30, 2022 USD ($)	Jul. 31, 2021 USD ($)	Jul. 25, 2020 USD ($)	Jul. 30, 2022 USD ($) patent	Jul. 30, 2022 USD ($)
Loss Contingencies [Line Items]
Future compensation expense & contingent consideration (up to)												$ 468,000,000			$ 468,000,000	$ 468,000,000
Commitments and contingencies
Volume of channel partner financing												27,900,000,000	26,700,000,000	$ 26,900,000,000
Balance of the channel partner financing subject to guarantees												1,400,000,000	1,300,000,000		$ 1,400,000,000	1,400,000,000
SRI International | Patent Infringement
Loss Contingencies [Line Items]
Number of allegedly infringed patents (patent) | patent											2
Damages paid, value																60,000,000
Damages awarded, value	$ 1,000,000
Centripetal | Pending Litigation | Patent Infringement | U.S.
Loss Contingencies [Line Items]
Number of allegedly infringed patents (patent) | patent									11
Damages awarded, value					$ 1,900,000,000
Number of patents found infringed (patent) | patent					4
Damages awarded, initial value					$ 756,000,000
Damages awarded, enhanced damages for willful infringement					1,100,000,000
Damages awarded, pre-judgement interest					$ 14,000,000
Royalty awarded against revenue, first three-year term, percentage					10.00%
Royalty awarded against revenue, second three-year term, percentage					5.00%
Centripetal | Pending Litigation | Patent Infringement | German
Loss Contingencies [Line Items]
Number of allegedly infringed patents (patent) | patent			1						6
Number of patents found not infringed (patent) | patent		2
Centripetal | Pending Litigation | Patent Infringement | European
Loss Contingencies [Line Items]
Number of allegedly infringed patents (patent) | patent			1			3
Centripetal | Pending Litigation | Patent Infringement, Not subject to IPR Proceedings | U.S.
Loss Contingencies [Line Items]
Number of allegedly infringed patents (patent) | patent									5
Ramot | Pending Litigation | Patent Infringement
Loss Contingencies [Line Items]
Number of allegedly infringed patents (patent) | patent				2				3
Viasat 1 | Contract claims
Loss Contingencies [Line Items]
Damages awarded, value							$ 49,000,000
Viasat 1 | Trade secret misappropriation
Loss Contingencies [Line Items]
Damages awarded, value							1
Viasat 1 | Counterclaim, contract and trade secret
Loss Contingencies [Line Items]
Damages awarded, value							$ 1
Egenera, Inc. | Pending Litigation | Patent Infringement
Loss Contingencies [Line Items]
Number of allegedly infringed patents (patent) | patent										3
Number of patents found not infringed (patent) | patent															2
Brazilian Tax Authority | Tax years 2003 through 2007
Loss Contingencies [Line Items]
Income tax examination, tax												156,000,000
Income tax examination, interest												822,000,000
Income tax examination, penalties												$ 387,000,000
Minimum
Loss Contingencies [Line Items]
Warranty period for products												90 days
Channel partners revolving short-term financing payment term												60 days
Minimum | Centripetal | Pending Litigation | Patent Infringement | U.S.
Loss Contingencies [Line Items]
Annual royalty awarded against revenue, first three-year term					$ 168,000,000
Annual royalty awarded against revenue, second three-year term					84,000,000
Maximum
Loss Contingencies [Line Items]
Warranty period for products												5 years
Channel partners revolving short-term financing payment term												90 days
Maximum | Centripetal | Pending Litigation | Patent Infringement | U.S.
Loss Contingencies [Line Items]
Annual royalty awarded against revenue, first three-year term					300,000,000
Annual royalty awarded against revenue, second three-year term					$ 150,000,000
Non-marketable equity securities and equity method investments
Loss Contingencies [Line Items]
Commitments and contingencies												$ 400,000,000	200,000,000		$ 400,000,000	400,000,000
Inventory
Loss Contingencies [Line Items]
Liability for purchase commitments												$ 313,000,000	$ 151,000,000		$ 313,000,000	$ 313,000,000